Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05481697 · ClinicalTrials.gov registry record · NA
Unintentional Weight Loss and Cancer: A Prospective Trial of Patient-centered Weight Tracking Combin
A NA study of Unintended Weight Loss, sponsored by Case Comprehensive Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 1,000
- Enrollment target
- 1
- Study location
NCT05481697 is a NA study of Unintended Weight Loss that is actively recruiting participants, run by Case Comprehensive Cancer Center. The registered enrollment target is 1,000 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05481697, a NA study of Unintended Weight Loss, is actively recruiting participants, sponsored by Case Comprehensive Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Unintentional weight loss (UWL) is commonly associated with a wide variety of diseases and there is still no valid diagnostic pathway for evaluating UWL. When detecting UWL coupled with GRAIL Galleri testing, (an investigational pan-cancer early detection test), it is thought that there is a greater positive predictive value in detecting malignancies. This study aims to test the potential synergistic effects of UWL detection and GRAIL usage to detect malignancy at an even earlier rate. UWL will be measured using weekly weight tracking.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST GRAIL Galleri
Study Locations (1)
Ohio
- University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2023-05-05 |
| Est. Completion | 2027-01-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05481697
The ClinicalTrials.gov registry entry for NCT05481697 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Unintended Weight Loss appearing as the primary indexed condition, and to 1 intervention - of which GRAIL Galleri is the first listed.
NCT05481697 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT05481697 about?
NCT05481697 is a clinical study titled "Unintentional Weight Loss and Cancer: A Prospective Trial of Patient-centered Weight Tracking Combin". Unintentional weight loss (UWL) is commonly associated with a wide variety of diseases and there is still no valid diagnostic pathway for evaluating UWL. When detecting UWL coupled with GRAIL Galleri testing, (an investigational pan-cancer early detection test), it is thought that there is a greater...
What is the current status of trial NCT05481697?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,000 participants. The study started on 2023-05-05. Estimated completion is 2027-01-01.
What conditions does trial NCT05481697 study?
This clinical trial studies the following conditions: Unintended Weight Loss.
What interventions are being tested in trial NCT05481697?
The interventions under investigation include: GRAIL Galleri (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05481697?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05481697 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.